Surprisingly, the administration of LIG was not effective in reverting any of the alterations noticed in insulin pathway protein expression; despite LIG being widely used for the therapy of diabetes [14], it had no efficacy in reverting signs of brain insulin resistance in our model. This evidence concerns the gene INS and Insulin resistance.